Compare CRON & ACHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRON | ACHC |
|---|---|---|
| Founded | N/A | 2005 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.1B |
| IPO Year | 2015 | 2011 |
| Metric | CRON | ACHC |
|---|---|---|
| Price | $2.55 | $23.22 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 14 |
| Target Price | N/A | ★ $21.64 |
| AVG Volume (30 Days) | 1.0M | ★ 3.3M |
| Earning Date | 05-28-2026 | 05-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $146,587,000.00 | ★ $3,312,769,000.00 |
| Revenue This Year | $32.15 | $5.23 |
| Revenue Next Year | $10.45 | $5.97 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 24.63 | 5.04 |
| 52 Week Low | $1.60 | $11.43 |
| 52 Week High | $3.43 | $31.04 |
| Indicator | CRON | ACHC |
|---|---|---|
| Relative Strength Index (RSI) | 45.95 | 61.01 |
| Support Level | $2.44 | $20.88 |
| Resistance Level | $2.59 | $25.07 |
| Average True Range (ATR) | 0.07 | 1.32 |
| MACD | -0.00 | -0.28 |
| Stochastic Oscillator | 30.33 | 38.86 |
Cronos Group Inc headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S., the company has an option to acquire 5.9% of U.S. multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The company's revenue is derived from services rendered to patients for inpatient psychiatric and substance abuse care, outpatient psychiatric care, and adolescent residential treatment.